JAK Inhibitors and Oxidative Stress Control

Primary Sjögren's syndrome (SjS) is a complex autoimmune epithelitis, with few treatment options, but the use of Janus kinase (JAK) inhibitors is promising because suppression of the JAK/signal transducer and activator of transcription (STAT) pathway improves sicca manifestations. Playing a pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Charras, Amandine, Arvaniti, Pinelopi, Le Dantec, Christelle, Dalekos, George N., Zachou, Kaliopi, Bordron, Anne, Renaudineau, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908489/
https://www.ncbi.nlm.nih.gov/pubmed/31867003
http://dx.doi.org/10.3389/fimmu.2019.02814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908489/
https://www.ncbi.nlm.nih.gov/pubmed/31867003
http://dx.doi.org/10.3389/fimmu.2019.02814

Ejemplares similares